Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3-Reference-Cited by-同舟云学术

Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3

Published:2011-06 Issue:3 Volume:13 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Kodera Yasuo,Katanasaka Yasufumi,Kitamura Yuka,Tsuda Hitoshi,Nishio Kazuto,Tamura Tomohide,Koizumi Fumiaki

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr2903.pdf

Reference34 articles.

1. Gupta GP, Massague J: Cancer metastasis: building a framework. Cell. 2006, 127: 679-695. 10.1016/j.cell.2006.11.001.

2. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K: Lymphangiogenesis and cancer metastasis. Nat Rev Cancer. 2002, 2: 573-583. 10.1038/nrc863.

3. Alitalo K, Tammela T, Petrova TV: Lymphangiogenesis in development and human disease. Nature. 2005, 438: 946-953. 10.1038/nature04480.

4. Joyce JA, Pollard JW: Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009, 9: 239-252. 10.1038/nrc2618.

5. Tammela T, Alitalo K: Lymphangiogenesis: molecular mechanisms and future promise. Cell. 2010, 140: 460-476. 10.1016/j.cell.2010.01.045.

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ZNF468-mediated epigenetic upregulation of VEGF-C facilitates lymphangiogenesis and lymphatic metastasis in ESCC via PI3K/Akt and ERK1/2 signaling pathways;Cellular Oncology;2024-08-14

2. Discovery of novel thiophene-3-carboxamide derivatives as potential VEGFR-2 inhibitors with anti-angiogenic properties;Bioorganic Chemistry;2024-06

3. Molecular biology of targeting lymphangiogenesis in cancer: Therapeutic strategies and future promise;Fundamental Research;2024-04

4. Tumor-associated myeloid cells in cancer immunotherapy;Journal of Hematology & Oncology;2023-07-06

5. Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target;Journal of Clinical Investigation;2023-07-03